News | February 22, 2010

Complimentary Atrial Fibrillation Symposium is March 13 at ACC

February 22, 2010 – The session “The Future is Now: Changing Paradigms in Atrial Fibrillation (AF) Management,” will take place 8 a.m. to noon Saturday, March 13 in Atlanta, Ga., in room A301, Georgia World Congress Center.

The complimentary symposium will address atrial fibrillation (AF) from a multifaceted, multidisciplinary approach. Participants will benefit from first-rate knowledge of the guidelines and synopses of cutting-edge developments by the world's leading experts in AF. The program will examine variations among clinicians in these settings, looking at both gaps in knowledge of and adherence to current guidelines as it relates to the future of AF care and its changing climate within the EP and cardiology community.

Participants will benefit from knowledge of the guidelines and synopses of cutting edge developments by some of the world's leading experts in AF. Areas of focus will include: anticoagulation and stroke prevention; cardioversion; heart failure in AF; appropriate selection and endpoints for anti-arrhythmic drug therapy; and patient selection and techniques surrounding catheter ablation to treat AF.

Presenters include Eric N. Prystowsky, M.D., FHRS,?The Care Group LLC; Philip B. Gorelick, M.D., MPH, University of Illinois College of Medicine at Chicago; Jonathan L. Halperin, M.D.,?Mt. Sinai Medical Center; Peter R. Kowey, M.D., FHRS,?Main Line Arrhythmia and Cardiology Consultants at Lankenau Hospital; and Francis E. Marchlinski, M.D., FHRS,?Hospital of the University of Pennsylvania

For more information: http://hrsonline.org/Education/Courses/AFSymp10/

Related Content

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in c
A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.
News | EP Lab | May 21, 2018
May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NR
Myocarditis is an Under-recognized Etiology of Symptomatic Premature Ventricular Arrhythmia (PVCs). #HRS #HRS2018
News | EP Lab | May 18, 2018
May 18, 2018 — A significant number of patients with symptomatic premature ventricular contractions (PVCs) have under
Novel Antibiotics Can Help Lower EP Device Infection Rates. Pictured here is an ICD. Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

News | EP Lab | May 17, 2018
May 10, 2018 – A new study is the first to test the clinical effectiveness of incremental peri-operative antibiotics
The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT). #HRS2018

The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT).  

News | EP Lab | May 16, 2018
May 16, 2018 — A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced
LivaNova Completes Sale of Cardiac Rhythm Management (CRM - electrophysiology) Business to MicroPort Scientific
News | EP Lab | April 30, 2018
April 30, 2018 — LivaNova announced it completed the sale of its cardiac rhythm management (CRM) business to MicroPor
LivaNova Enters Binding Letter of Intent to Sell Cardiac Rhythm Management Business
News | EP Lab | January 26, 2018
January 26, 2018 — LivaNova PLC and MicroPort Scientific Corp.
Societies Detail Treatment for Patients With Ventricular Arrhythmias
News | EP Lab | October 30, 2017
The American College of Cardiology, along with the American Heart Association and the Heart Rhythm Society, published...
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab | October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Spectranetics Initiates Class I Recall for Bridge Occlusion Balloon Catheter
News | EP Lab | September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Overlay Init